Rate My Professor Anna-Marie Babey

Babey's primary research areas encompass neuropharmacology, genetics, and the scholarship of teaching and learning. Her interests include signal transduction changes underlying tolerance to opioid analgesics and caffeine, Lesch-Nyhan syndrome—an X-linked genetic deficiency of hypoxanthine phosphoribosyltransferase—drug discovery screening for novel anti-tumour compounds, and pharmacology education research. She is a member of the International Union of Basic and Clinical Pharmacology Education Section Core Concepts of Pharmacology Project Research Team and the Australian Physiological Society Core Concepts of Physiology Task Force. Babey teaches pharmacology, genetics, and physiology in units such as Introduction to Genetics, Integrated Physiology Skills, and Pharmacology for Research, as well as in the Joint Medical Program. In 2025, she received the ASCEPT Elizabeth Davis Teaching Excellence Award. Key publications include "Synthesis of the mechanisms of opioid tolerance: do we still say NO?" (Cell Mol Neurobiol, 2021), "Identifying the core concepts of pharmacology education" (Pharmacol Res Perspect, 2021), "Defining and unpacking the core concepts of pharmacology: a global initiative" (Br J Pharmacol, 2024), "Developing an international concept-based curriculum for pharmacology education" (Br J Clin Pharmacol, 2023), and "Nitric oxide and opioid tolerance" (Neuropharmacology, 1994). She holds roles such as Councillor for the IUPHAR Education Section, Co-Chair of the IUPHAR-Ed Online Meeting Steering Group, and Executive member of the ASCEPT Education Forum.